Viewing Study NCT06414655



Ignite Creation Date: 2024-05-19 @ 5:33 PM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06414655
Status: RECRUITING
Last Update Posted: 2024-05-16
First Post: 2024-03-17

Brief Title: Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China
Sponsor: Peking University Third Hospital
Organization: Peking University Third Hospital

Study Overview

Official Title: Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China
Status: RECRUITING
Status Verified Date: 2024-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ChiTwiMC
Brief Summary: Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China ChiTwiMC is supported by National Key Research and Development Program of China - Reproductive Health and Womens and Childrens Health Protection Project This project is funded by the Ministry of Science and Technology of China under grant number 2023YFC2705900 The ChiTwiMC cohort is led by Professor Wei Yuan from the Department of Gynecology and Obstetrics at Peking University Third Hospital
Detailed Description: The ChiTwiMC Cohort focusing on the serious complications of twin pregnancy establish a multicenter large prospective mother-child cohort of twin pregnancy covering pregnancyneonatal periodearly childhood and a multi-variety multi-stage biobank for the study of adverse outcomes of twin pregnancy The ChiTwiMC Cohort is planning to recruit 2000 pregnant women aged 18-45 years from 9 large obstetrical center of major University-affiliated Hospitals across China between December 2023 and May 2026 All women will be enrolled prior to 14 wks of gestation pregnancy was followed up at 22-28 wks 30-38 wks of gestation delivery postpartum 42 days 6 months 12 months Data including demographics medical history reproductive history clinical diagnosis treatment information and pregnancy and birth outcomes will be collected via electronic data capture system Track the outcome of severe maternal-fetal complications and early neonatal outcomes of twins and collect biological samples including peripheral venous blood hair and cervicovaginal secretions from pregnant women placenta tissue amniotic fluid and unbilical cord blood at delivery meconium and hair from newborns buccal mucosa from infants and peripheral venous blood from the husband

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None